August 29, 2014 4:13 AM ET

Life Sciences Tools and Services

Company Overview of Seahorse Bioscience, Inc.

Company Overview

Seahorse Bioscience, Inc. engages in the design, development, manufacture, and supply of analytical instruments, biomanufacturing systems, and consumable labware products for biological research and drug discovery to the life sciences industry. It offers a line of extracellular flux (XF) instruments, including XFe96 and XFe24 analyzers that measure mitochondrial respiration and glycolysis in cells; XF24-3 analyzer that enables the measurement of the TCA cycle, as well as mitochondrial respiration and glycolysis; and XF prep station that removes growth medium replacing with run medium. The company’s consumable products include XF fluxpaks, cell culture and islet capture microplates, stress te...

16 Esquire Road

North Billerica, MA 01862

United States

Founded in 2000

Phone:

978-671-1600

Fax:

978-671-1611

Key Executives for Seahorse Bioscience, Inc.

Founder
Age: 57
Founder and Vice President of Seahorse Labware
Founder and Vice President of Administration & Finance
Founder and Chief Technology Officer
Founder and Vice President of Sales & Marketing
Compensation as of Fiscal Year 2014.

Seahorse Bioscience, Inc. Key Developments

Seahorse Bioscience, Inc. Presents at Jefferies 2013 Global Healthcare Conference, Jun-03-2013 08:00 AM

Seahorse Bioscience, Inc. Presents at Jefferies 2013 Global Healthcare Conference, Jun-03-2013 08:00 AM. Venue: Grand Hyatt Hotel, 109 East 42nd Street at Grand Central, New York, New York, United States. Speakers: Jay Teich, Founder, Chairman, Chief Executive Officer and President.

Seahorse Bioscience Launches the XF Plasma Membrane Permeabilizer

Seahorse Bioscience recently launched the XF Plasma Membrane Permeabilizer (PMP), a reagent that enables scientists to measure the biochemistry and mechanisms of mitochondrial dysfunction, without the need for mitochondrial isolation or detergent-based permeabilization methods. XF PMP was developed in partnership with the Pioneer Valley Life Sciences Institute (PVLSI), a joint venture of Baystate Medical Center and the University of Massachusetts Amherst, with the dual missions of biomedical research and economic development. The technology was exclusively licensed to Seahorse Bioscience by UMass Amherst and Baystate Health, the parent organization of Baystate Medical Center. XF PMP can be used with the Seahorse XF(e) Extracellular Flux Analyzer, an instrument for measuring cell metabolism, in real-time, in a microplate. XF PMP creates pores in the cell plasma membrane, and delivers a degree of precision and ease-of-use that has not been available to scientists researching cell metabolism. A key element of XF PMP is the ability to assess mitochondrial function in adherent monolayers of permeabilized cells without damaging the mitochondrial membrane. By doing so, XF PMP enables metabolic substrates, compounds, and small proteins that otherwise would not cross the plasma membrane to reach the mitochondria.

Similar Private Companies By Industry

Company Name Region
Centurion Sterilization Services United States
Carmenta Bioscience, Inc. United States
ConfometRx, Inc. United States
Buffalo Clinical Research Center, LLC United States
Promega Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Seahorse Bioscience, Inc., please visit www.seahorsebio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.